|
WO2014109842A2
|
|
Nanotechnology based medicine for biodefense
|
|
JP2009286808A
|
|
Composition and method for targeted delivery of biologically-active factors
|
|
US2009148908A1
|
|
Compositions and methods for generating antibodies
|
|
CN102203002A
|
|
Nanotherapeutic colloidal metal compositions and methods
|
|
WO2005072893A1
|
|
Functionalized colloidal metal compositions and methods
|
|
AU2004311630A1
|
|
Methods and compositions for the production of monoclonal antibodies
|
|
AU2003231660A1
|
|
Compositions and methods for targeted delivery of factors
|
|
WO02087509A2
|
|
Colloidal metal compositions and methods
|
|
US7229841B2
|
|
Colloidal metal compositions and methods
|
|
NZ504292A
|
|
Methods and compositions for enhancing immune response using a targeted delivery system and for the production of in vitro mabs
|
|
US6407218B1
|
|
Method and compositions for enhancing immune response and for the production of in vitro mabs
|
|
EP1044022A2
|
|
Compositions and methods for targeted delivery of factors
|
|
US6274552B1
|
|
Composition and method for delivery of biologically-active factors
|
|
US5965379A
|
|
Method for measuring endogenous cytokines
|
|
EP0690722A1
|
|
Composition and method for reducing toxicity of biologically-active factors
|
|
EP0598758A1
|
|
Method and kit for measuring endogenous cytokines
|
